Lupin inks pact to acquire two inhalation brands from Sunovion for $75 million
NEW DELHI: Drug maker Lupin on Thursday said it will acquire two inhalation brands from Sunovion Pharmaceuticals Inc for USD 75 million (around Rs 622 crore). The drug firm has inked a pact with US-based Sunovion to acquire Brovana (arformoterol tartrate) inhalation solution and Xopenex HFA (levalbuterol tartrate) inhalation aerosol. The Mumbai-based firm expects the […]
Lupin Q4 net profit up 18% at Rs 460 crore; FY21 profit at Rs 1,216 crore
NEW DELHI: Drug maker Lupin on Thursday reported an 18 per cent increase in its consolidated net profit at Rs 460 crore for the fourth quarter ended March 31, 2021, driven by robust sales across domestic and international markets. The Mumbai-based company had reported a net profit of Rs 390 crore in the January-March quarter […]
US FDA grants orphan drug status to mexiletine hydrochloride: Lupin
NEW DELHI: Pharma major Lupin on Monday said the US health regulator has granted orphan drug designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders. The Mumbai-based company’s drug NaMuscula (mexiletine hydrochloride) is the first and only licensed product to treat myotonia in adults with non-dystrophic myotonic (NDM) disorders. The company has already […]
Lupin launches Levothyroxine Sodium tablets in USA
NEW DELHI: Drug firm Lupin on Friday said it has launched generic Levothyroxine Sodium tablets in the USA market. The company has launched Levothyroxine Sodium tablets USP after receiving approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a BSE filing. The company’s product is the generic version of AbbVie […]